RNA isolation from soluble urine fractions

    公开(公告)号:US11193120B2

    公开(公告)日:2021-12-07

    申请号:US16692355

    申请日:2019-11-22

    Abstract: The invention provides methods for isolating RNA from the soluble fraction of urine. The methods can be used for detecting the presence or absence of an RNA, or quantifying the amount of an RNA. The methods are useful for diagnosing an individual suspected of having a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine. The methods are also useful for prognosing an individual diagnosed with a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine.

    RNA ISOLATION FROM SOLUBLE URINE FRACTIONS
    13.
    发明申请

    公开(公告)号:US20200157527A1

    公开(公告)日:2020-05-21

    申请号:US16692355

    申请日:2019-11-22

    Abstract: The invention provides methods for isolating RNA from the soluble fraction of urine. The methods can be used for detecting the presence or absence of an RNA, or quantifying the amount of an RNA. The methods are useful for diagnosing an individual suspected of having a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine. The methods are also useful for prognosing an individual diagnosed with a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine.

    RNA ISOLATION FROM SOLUBLE URING FRACTIONS
    14.
    发明申请

    公开(公告)号:US20190062726A1

    公开(公告)日:2019-02-28

    申请号:US16118864

    申请日:2018-08-31

    Abstract: The invention provides methods for isolating RNA from the soluble fraction of urine. The methods can be used for detecting the presence or absence of an RNA, or quantifying the amount of an RNA. The methods are useful for diagnosing an individual suspected of having a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine. The methods are also useful for prognosing an individual diagnosed with a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine.

Patent Agency Ranking